Pharmaceuticals, Biotechnology and Life Sciences
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc., a privately held, clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to…
Assets to further enhance ZYUS cannabinoid clinical trial program SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Inc. (“ZYUS” or the “Company”) has…
Assets to further enhance ZYUS cannabinoid clinical trial program SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Inc. (“ZYUS” or the “Company”) has…
Recruitment completed in investigator-sponsored Phase 1 Fabry study Phase 1 and Phase 2 clinical data updates for AVR-RD-01 in Fabry…
Recruitment completed in investigator-sponsored Phase 1 Fabry study Phase 1 and Phase 2 clinical data updates for AVR-RD-01 in Fabry…
Urges Shareholders to Vote “FOR” the Proposed Transaction on the WHITE Proxy Card NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company’s (NYSE:BMY) Board…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…
DUBLIN–(BUSINESS WIRE)–The “Animal Biotechnology – Technologies, Markets and Companies” report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering. This…
CHENGDU, China–(BUSINESS WIRE)–HitGen Ltd announced that the company has entered into a research collaboration with Almirall to identify novel small…
Funding in excess of US$1 million to support the development of a brain imaging probe for patient diagnosis and the…